News and Trends 23 May 2023
HuidaGene Therapeutics creates world’s first ‘G to Y’ DNA base-editor
HuidaGene Therapeutics, a clinical-stage genome-editing company, says the National Science Review has published data from its study of the world's…
DNA
- Latest Posts
News and Trends 5 May 2023
‘Birth of a chromosome’ could boost cancer and infertility research
Most chromosomes have been around for millions of years. However, researchers from the Stowers Institute for Medical Research have revealed…
News and Trends 5 May 2023
Exothera partners with Quantoom and launches DNA business unit
Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA. The…
Sponsored by Quantoom Biosciences
4 May 2023How is Quantoom Biosciences’ Ntensify™ technology changing mRNA production?
Quantoom Biosciences has just launched Ntensify™, the world’s first continuous mRNA production technology that is set to revolutionize the entire…
ADVERTISEMENT
News and Trends 26 Apr 2023
20Med Therapeutics and Touchlight collaborating on novel vaccine delivery platform
20Med Therapeutics, a company working on non-viral delivery and development of gene therapies and vaccines, and Touchlight, a biotechnology company…
News and Trends 17 Mar 2023
How cancer cells repair DNA damage from radiotherapy
A team of scientists led by Kei-ichi Takata from the Center for Genomic Integrity (CGI) within the Institute for Basic…
In Depth 10 Mar 2023
Can CRISPR bring back extinct animals?
The concept of de-extinction has been around for many years. Once considered a fanciful idea, recent advancements in technology -…
News and Trends 3 Mar 2023
Debiopharm adds to oncology pipeline
Debiopharm, an independent Swiss-based, biopharmaceutical company, has obtained the global rights for FT-3171, a small molecule USP1 inhibitor program targeting…
News and Trends 10 Feb 2023
Beyond Biotech podcast 33: Astellas Pharma, Innovation Agency Lithuania, 4basebio
This week, our guests are Romualda Stragienė, director at Innovation Agency Lithuania and Andrius Sliuzas, export key account manager of…
News and Trends 3 Feb 2023
AI boosts genome editing
Researchers at the University of Zurich have developed a new tool that uses artificial intelligence to predict the efficacy of…
News and Trends 2 Feb 2023
AstraZeneca creates FRAGLER for DNA synthesis
“Plasmids are critical for so many processes in early drug discovery,” says David Öling, associate principal scientist at AstraZeneca. “From…
News and Trends 23 Dec 2022
Watch: Eva Hoffmann talks about genetics and fertility
Eva R. Hoffmann is the Professor in Molecular Genetics at the Department of Cellular and Molecular Medicine at the University…
News and Trends 21 Dec 2022
Artificial DNA can kill cancer
Researchers at the University of Tokyo in Japan have used artificial DNA to target and kill cancer cells in a…
News and Trends 20 Dec 2022
Ribbon Biolabs milestone to lead to 2023 market entry
DNA synthesis company Ribbon Biolabs has announced the successful implementation of its InfiniSynth platform for the automated assembly of sequence-agnostic…
Startup Scout 13 Dec 2022
Biomemory is making DNA hard drives cheap and sustainable
The world is running out of ways to store the mountains of data we produce. Biomemory is creating DNA-based hard…
News and Trends 8 Dec 2022
DNA repair mechanism study could boost cancer treatment
A better understanding of the mechanisms involved in DNA repair may pave the way for developing inhibitors to improve the…
ADVERTISEMENT
News and Trends 8 Dec 2022
Polyplus announces completion of acquisition of Xpress Biologics to expand plasmid DNA
Polyplus has announced the completion of an acquisition of Belgian Xpress Biologics to expand plasmid DNA technology. Xpress Biologics specializes…
